Both in Pharmaceuticals
MBX Biosciences vs Prestige Consumer Healthcare
Over the past year MBX returned +184.7% and PBH returned −19.1%; their daily moves had a correlation of -0.02.
MBX +184.7% PBH −19.1%Growth of $1, one year, split-adjusted
| Metric | MBX | PBH |
|---|---|---|
| Price | $55.58 | $49.14 |
| Market cap | $2.68B | $2.33B |
| Today | +1.91% | +0.80% |
| 1 month | −1.7% | +9.8% |
| 6 months | +86.6% | −10.8% |
| Year to date | +76.2% | −20.3% |
| 1 year | +184.7% | −19.1% |
| Revenue growth (YoY) | — | +6.5% |
| Gross margin | — | 51.3% |
| Net margin | — | 11.0% |
| P/E (TTM) | — | 13.5× |
| Price / sales | — | 2.1× |
| Net cash | — | -$1.95B |
| Dividend yield | — | — |
| Volatility (60d) | 47.5% | 30.7% |
| Short % of float | 15.0% | 8.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).